These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32859404)

  • 21. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.
    Varì MR; Mannocchi G; Tittarelli R; Campanozzi LL; Nittari G; Feola A; Umani Ronchi F; Ricci G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic cathinone adulteration of illegal drugs.
    Oliver CF; Palamar JJ; Salomone A; Simmons SJ; Philogene-Khalid HL; Stokes-McCloskey N; Rawls SM
    Psychopharmacology (Berl); 2019 Mar; 236(3):869-879. PubMed ID: 30338489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intended and unintended use of cathinone mixtures.
    Guirguis A; Corkery JM; Stair JL; Kirton SB; Zloh M; Schifano F
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019.
    Palamar JJ; Salomone A
    Am J Addict; 2021 Jan; 30(1):49-54. PubMed ID: 32813326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cathinones use in Paris].
    Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S
    Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of synthetic cathinones emerging in recent years (2019-2022).
    Kuropka P; Zawadzki M; Szpot P
    Forensic Toxicol; 2023; 41(1):25-46. PubMed ID: 36124107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.
    Rodrigues CHP; Mariotto LS; Castro JS; Peruquetti PH; Silva-Junior NC; Bruni AT
    Forensic Toxicol; 2023 Jul; 41(2):187-212. PubMed ID: 36604359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
    Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
    Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
    Palamar JJ; Salomone A; Gerace E; Di Corcia D; Vincenti M; Cleland CM
    Int J Drug Policy; 2017 Oct; 48():91-98. PubMed ID: 28810159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].
    Batisse A; Peyrière H; Eiden C; Courné MA; Djezzar S;
    Therapie; 2016 Oct; 71(5):447-455. PubMed ID: 27203172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
    Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm.
    Sutherland R; Allsop S; Peacock A
    Curr Opin Psychiatry; 2020 Jul; 33(4):343-351. PubMed ID: 32250983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic cathinones - From natural plant stimulant to new drug of abuse.
    Pieprzyca E; Skowronek R; Nižnanský Ľ; Czekaj P
    Eur J Pharmacol; 2020 May; 875():173012. PubMed ID: 32087255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addictovigilance in women, the hidden part of the iceberg?
    Lapeyre-Mestre M
    Therapie; 2023; 78(2):157-164. PubMed ID: 36280399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
    Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI;
    Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.